Central Retinal Vein Occlusion After Discontinuation of Rivaroxaban Therapy in a Young Patient with COVID-19 Pulmonary Embolism: A Case Report

Bernadetta Płatkowska-Adamska; Magdalena Kal; Joanna Krupińska; Michał Biskup; Dominik Odrobina

doi:10.12659/AJCR.937739

01 November 2022: Articles

Central Retinal Vein Occlusion After Discontinuation of Rivaroxaban Therapy in a Young Patient with COVID-19 Pulmonary Embolism: A Case Report

Unusual clinical course, Unusual or unexpected effect of treatment, Unexpected drug reaction

Bernadetta Płatkowska-Adamska ^A* , Magdalena Kal ^B , Joanna Krupińska ^B , Michał Biskup ^A , Dominik Odrobina ^D

DOI: 10.12659/AJCR.937739

Am J Case Rep 2022; 23:e937739

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

View HTML version

Figure 2. Fluorescein angiogram of the right eye: (A) the arteriovenous phase and (B) the late phase showing masking by hemorrhages and staining of vessel walls with good capillary perfusion.

Back to the Article

Central Retinal Vein Occlusion After Discontinuation of Rivaroxaban Therapy in a Young Patient with COVID-19 Pulmonary Embolism: A Case Report

Your Privacy